NU
NUWE.US Nuwellis Inc
- Market cap
- USD 2.65M
- P/E
- 0.0x
- P/B
- 0.18x
- ROE
- -150.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NUWE.US undervalued?
Graham numberThe Graham number of Nuwellis Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nuwellis Inc fundamental analysis
No fundamental analysis for Nuwellis Inc yet.
Nuwellis Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 20…
Full company profileNuwellis Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nuwellis Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.29M | 3.55M | 5.00M | 5.51M | 7.44M | 7.92M | 8.54M | 8.86M | 8.74M | 8.27M | 8.78M |
| Gross Profit | 576K | 790K | 1.33M | 2.85M | 4.06M | 4.49M | 4.76M | 4.98M | 5.83M | 5.12M | 6.29M |
| Operating Income | -15.7M | -14.8M | -17.0M | -18.1M | -17.0M | -19.5M | -17.2M | -17.6M | -11.0M | -11.1M | -12.8M |
| EBITDA | -14.6M | -10.1M | -16.8M | -17.9M | -16.7M | -19.1M | -4.90M | -16.4M | -10.5M | -6.55M | -10.3M |
| Net Income | -15.8M | -13.4M | -17.0M | -18.1M | -15.8M | -19.6M | -14.5M | -20.2M | -11.2M | -17.5M | -14.8M |
| EPS | -225,600,000 | -191,171,429 | -170,320,000 | -17,251,429 | -851,398 | -419,614 | -122,719 | -15,123 | -353 | -800 | -44 |
| Balance Sheet | |||||||||||
| Total Assets | 7.47M | 18.5M | 8.78M | 5.60M | 20.0M | 30.4M | 24.7M | 9.77M | 9.86M | 6.12M | 13.4M |
| Total Liabilities | 5.71M | 2.22M | 2.84M | 3.61M | 3.69M | 4.47M | 12.3M | 6.56M | 3.33M | 3.49M | 3.59M |
| Shareholders' Equity | 1.76M | 16.2M | 5.94M | 1.99M | 16.3M | 25.9M | 12.4M | 3.21M | 6.53M | 2.62M | 9.85M |
| Cash & Short-term Investments | 1.32M | 15.6M | 5.48M | 1.28M | 14.4M | 24.2M | 18.3M | 3.80M | 5.10M | 1.09M | 8.29M |
| Total Debt | - | - | - | 447K | 339K | 1.18M | 984K | 760K | 545K | 328K | 135K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -16.3M | -11.9M | -14.6M | -16.4M | -16.6M | -17.8M | -15.1M | -17.9M | -9.59M | -10.8M | -12.4M |
| Capital Expenditure | 117K | 259K | 198K | 490K | 298K | 219K | 122K | 248K | 60.0K | 90.0K | 81.3K |
| Free Cash Flow | -16.4M | -12.2M | -14.8M | -16.9M | -16.9M | -18.1M | -15.3M | -18.2M | -9.65M | -10.9M | -12.4M |
| Ratios | |||||||||||
| ROE | -898.8% | -82.4% | -286.9% | -910.3% | -97.0% | -75.4% | -117.5% | -629.4% | -171.0% | -667.7% | -150.8% |
| ROA | -211.4% | -72.5% | -194.1% | -323.3% | -79.1% | -64.3% | -58.9% | -206.8% | -113.2% | -286.4% | -110.4% |
| Net Profit Margin | -1,225.1% | -376.6% | -340.8% | -328.7% | -212.8% | -246.9% | -170.0% | -228.0% | -127.7% | -211.9% | -169.1% |
| Debt to Equity | - | - | - | 0.22x | 0.02x | 0.05x | 0.08x | 0.24x | 0.08x | 0.13x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nuwellis Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | USD 541K | 17 | - |
| 2023 | USD 2.30M | 1,719 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:9 on Oct 27, 2026.
Who owns Nuwellis Inc
- Insiders 3.72%
- Institutions 5.89%
- Public & others 90.39%
- Shares outstanding 541K
- Free float 384K
Top funds holding NUWE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 22.7K | 0.62% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 42.00 | 0.00% | 0.00% | Sep 2026 |
Top institutions holding NUWE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Sabby Management LLC | 16.4K | 0.45% | 0.00% | Jun 2026 |
| UBS Group AG | 4.42K | 0.12% | +441,400.00% | Jun 2026 |
| Tower Research Capital LLC | 138.00 | 0.00% | -6.76% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 35.00 | 0.00% | 0.00% | Jun 2026 |
| SBI Securities Co Ltd | 4.00 | 0.00% | +100.00% | Jun 2026 |
| Ankerstar Wealth, LLC | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Armistice Capital, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Citigroup Inc | 0.00 | 0.00% | -100.00% | Jun 2026 |
Nuwellis Inc company profile
- Company name
- Nuwellis Inc
- Ticker
- NUWE.US
- Exchange
- USA Stocks
- Listed since
- Feb 16, 2012
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 38
- Fiscal year end
- December
- Address
- 12988 Valley View Road, Eden Prairie, MN, United States, 55344
- Phone
- 952 345 4200
- Website
- nuwellis.com
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis Inc management
7- Mr. Michael Kendrick McCormickPresident, CEO & Director · born 1962
- Mr. Neil P. Ayotte Esq.Senior VP, General Counsel, Secretary & Chief Compliance Officer · born 1963
- Ms. Carisa SchultzCFO, Principal Financial Officer & Principal Accounting Officer · born 1978
- Ms. Kim AndersonVice President, Research & Development, Quality and Operations
- Mr. David LernerChief Technology Officer
- Leah McMullenDirector of Communications
- Mr. Paul WottaCorporate Controller · born 1958